I Mab Performance
| IMABDelisted Stock | USD 4.64 0.06 1.28% |
On a scale of 0 to 100, I Mab holds a performance score of 6. The firm retains a Market Volatility (i.e., Beta) of -0.5, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning I Mab are expected to decrease at a much lower rate. During the bear market, I Mab is likely to outperform the market. Please check I Mab's maximum drawdown, semi variance, and the relationship between the sortino ratio and potential upside , to make a quick decision on whether I Mab's current trending patterns will revert.
Risk-Adjusted Performance
Mild
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in I Mab are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, I Mab sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 2.2 B | |
| Total Cashflows From Investing Activities | -136 M |
IMAB |
I Mab Relative Risk vs. Return Landscape
If you would invest 435.00 in I Mab on October 6, 2025 and sell it today you would earn a total of 29.00 from holding I Mab or generate 6.67% return on investment over 90 days. I Mab is currently generating 0.6668% in daily expected returns and assumes 8.4997% risk (volatility on return distribution) over the 90 days horizon. In different words, 76% of stocks are less volatile than IMAB, and 87% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
I Mab Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for I Mab's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as I Mab, and traders can use it to determine the average amount a I Mab's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0784
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | IMAB | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average I Mab is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of I Mab by adding it to a well-diversified portfolio.
I Mab Fundamentals Growth
IMAB Stock prices reflect investors' perceptions of the future prospects and financial health of I Mab, and I Mab fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on IMAB Stock performance.
| Return On Equity | -0.18 | |||
| Return On Asset | -0.1 | |||
| Current Valuation | 313.92 M | |||
| Shares Outstanding | 115.27 M | |||
| Price To Book | 2.42 X | |||
| Price To Sales | 25.39 X | |||
| EBITDA | (373.45 M) | |||
| Cash And Equivalents | 3.92 B | |||
| Cash Per Share | 47.20 X | |||
| Total Debt | 3.88 M | |||
| Debt To Equity | 0.03 % | |||
| Book Value Per Share | 2.40 X | |||
| Cash Flow From Operations | (52.67 M) | |||
| Earnings Per Share | (0.51) X | |||
| Total Asset | 212.68 M | |||
| Retained Earnings | (1.29 B) | |||
| Current Asset | 1.51 B | |||
| Current Liabilities | 527.75 M | |||
About I Mab Performance
By analyzing I Mab's fundamental ratios, stakeholders can gain valuable insights into I Mab's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if I Mab has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if I Mab has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. The company was founded in 2014 and is headquartered in Shanghai, the Peoples Republic of China. I-Mab ADR operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 378 people.Things to note about I Mab performance evaluation
Checking the ongoing alerts about I Mab for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for I Mab help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| I Mab is now traded under the symbol NBP. Please update your portfolios or report it if you believe this is an error. Report It! | |
| I Mab is not yet fully synchronised with the market data | |
| I Mab is way too risky over 90 days horizon | |
| I Mab appears to be risky and price may revert if volatility continues | |
| I Mab has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (49.7 M) with profit before overhead, payroll, taxes, and interest of 41.59 M. | |
| I Mab currently holds about 3.92 B in cash with (52.67 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 47.2, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 21.0% of the company shares are held by company insiders |
- Analyzing I Mab's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether I Mab's stock is overvalued or undervalued compared to its peers.
- Examining I Mab's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating I Mab's management team can have a significant impact on its success or failure. Reviewing the track record and experience of I Mab's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of I Mab's stock. These opinions can provide insight into I Mab's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Consideration for investing in IMAB Stock
If you are still planning to invest in I Mab check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the I Mab's history and understand the potential risks before investing.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |